title: Reply re: "Treating Buccinator with Botulinum Toxin in Patients with Facial Synkinesis: A Previously Overlooked Target".
authors.forename: Mark J
authors.initials: MJ
authors.lastname: Lucarelli
authors.forename: Leslie A
authors.initials: LA
authors.lastname: Wei
authors.forename: Jacqueline
authors.initials: J
authors.lastname: Diels
mesh_terms: D001905:Botulinum Toxins; D019274:Botulinum Toxins, Type A; D005145:Face; D005152:Facial Muscles; D005158:Facial Paralysis / Q000188:drug therapy; D006801:Humans; D009465:Neuromuscular Agents / Q000627:therapeutic use; D046608:Synkinesis / Q000188:drug therapy*
chemical_list: D009465:Neuromuscular Agents; D001905:Botulinum Toxins; D019274:Botulinum Toxins, Type A